Literature DB >> 679594

Plasma protein binding and distribution characteristics of drugs as indices of their hemodialyzability.

P R Gwilt, D Perrier.   

Abstract

The dialysis clearance, plasma protein binding, and distribution (expressed as volume of distribution) characteristics of a drug were evaluated as predictive indices of the efficiency of hemodialysis in removing drug from the body. Dialysis clearance correlated poorly with the fraction of drug in the body removed by hemodialysis. The best predictive measure of hemodialysis efficiency was obtained by a nonlinear model relating the ratio of the percent of free drug in the plasma and the volume of distribution of the drug to the fraction removed. Knowledge of the binding and distribution characteristics of a drug provides insight into the dialyzability of a drug which in turn may assist in coming to decisions on the necessity of dose adjustments for patients on chronic hemodialysis and the rational use of hemodialysis in the treatment of drug intoxication.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 679594     DOI: 10.1002/cpt1978242154

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  22 in total

Review 1.  Effect of haemodialysis on the pharmacokinetics of antineoplastic drugs.

Authors:  Masatoshi Tomita; Yoichi Aoki; Kenichi Tanaka
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

2.  Tolerable sorafenib therapy for a renal cell carcinoma patient with hemodialysis: a case study.

Authors:  Keiko Shinsako; Tomoyuki Mizuno; Tomohiro Terada; Jun Watanabe; Tomomi Kamba; Eijiro Nakamura; Osamu Ogawa; Ken-ichi Inui
Journal:  Int J Clin Oncol       Date:  2010-03-26       Impact factor: 3.402

3.  Haemodialysis of pyrazinamide in uraemic patients.

Authors:  C Lacroix; A Hermelin; R Guiberteau; C Guyonnaud; J Nouveau; H Duwoos; O Lafont
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

Review 4.  Drug removal by continuous arteriovenous haemofiltration. A review of the evidence in poisoned patients.

Authors:  T A Golper; W M Bennett
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Sep-Oct

Review 5.  A review of drug prescribing in children with end-stage renal failure.

Authors:  R S Trompeter
Journal:  Pediatr Nephrol       Date:  1987-04       Impact factor: 3.714

Review 6.  Clinical pharmacokinetics of aminoglycoside antibiotics.

Authors:  J C Pechere; R Dugal
Journal:  Clin Pharmacokinet       Date:  1979 May-Jun       Impact factor: 6.447

7.  Predicative calculation of the efficiency of hemodialysis or hemoperfusion for the removal of drugs from the body.

Authors:  H H Wellhöner
Journal:  Arch Toxicol       Date:  1985-01       Impact factor: 5.153

8.  Toxicokinetics of labeled amatoxins in the dog.

Authors:  H Faulstich; A Talas; H H Wellhöner
Journal:  Arch Toxicol       Date:  1985-01       Impact factor: 5.153

9.  Pharmacokinetics of tinidazole in chronic renal failure and in patients on haemodialysis.

Authors:  B L Flouvat; C Imbert; D M Dubois; B P Temperville; A F Roux; G C Chevalier; G Humbert
Journal:  Br J Clin Pharmacol       Date:  1983-06       Impact factor: 4.335

Review 10.  Protein binding as a primary determinant of the clinical pharmacokinetic properties of non-steroidal anti-inflammatory drugs.

Authors:  J H Lin; D M Cocchetto; D E Duggan
Journal:  Clin Pharmacokinet       Date:  1987-06       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.